nimodipine has been researched along with Pulmonary Hypertension in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case is reported in which intravenous nimodipine therapy was associated with severe acute pulmonary hypertension in a patient with a subarachnoid haemorrhage." | 3.68 | Pulmonary vasoconstriction following intravenous nimodipine. ( Lovell, AT; Smith, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lovell, AT | 1 |
| Smith, M | 1 |
1 other study available for nimodipine and Pulmonary Hypertension
| Article | Year |
|---|---|
Pulmonary vasoconstriction following intravenous nimodipine.
Topics: Humans; Hypertension, Pulmonary; Male; Middle Aged; Nimodipine; Pulmonary Artery; Subarachnoid Hemor | 1992 |